Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Xarelto
Xarelto
In a setback, Bayer, J&J say their big PhIII secondary stroke trial for Xarelto failed
Endpoints
Fri, 10/6/17 - 09:47 am
Bayer
JNJ
stroke
clinical trials
Xarelto
bloodthinners
10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright
Motley Fool
Sun, 09/17/17 - 09:56 am
JNJ
Remicade
Stelara
drug pricing
Imbruvica
Xarelto
Darzalex
devices
consumer health
ESC 2017 – Bleeding blunts Xarelto’s Compass victory
EP Vantage
Sun, 08/27/17 - 05:48 pm
European Society of Cardiology
Xarelto
bloodthinners
Bayer
J&J
Bayer, J&J win third U.S. trial over Xarelto bleeding risk
Yahoo/Reuters
Sat, 08/19/17 - 10:32 am
Bayer
JNJ
Xarelto
bloodthinners
Johnson & Johnson, Bayer score a second key win in Xarelto bleeding litigation
Fierce Pharma
Tue, 06/13/17 - 11:55 am
JNJ
Bayer
Xarelto
bloodthinners
J&J, Bayer prevail in bellwether Xarelto trial
Fierce Pharma
Thu, 05/4/17 - 09:50 am
JNJ
Bayer
Xarelto
bloodthinners
J&J, Bayer face first jury trial over blockbuster Xarelto's bleedings risks
Fierce Pharma
Wed, 04/26/17 - 11:48 am
JNJ
Bayer
Xarelto
J&J, Bayer Accused of Hiding Blood-Thinning Drug's Flaws
Bloomberg
Mon, 04/24/17 - 10:15 pm
JNJ
Bayer
bloodthinners
Xarelto
J&J's Remicade sees 'very little' biosim erosion, but payers are sticking it to Xarelto
Fierce Pharma
Tue, 04/18/17 - 09:03 pm
JNJ
Remicade
biosimilars
payers
Xarelto
Inflectra
J&J and Bayer's Xarelto cuts recurrence of dangerous blood clots in study
Yahoo/Reuters
Sun, 03/19/17 - 11:22 am
JNJ
Bayer
Xarelto
blood clots
bloodthinners
Many at risk for stroke don’t get anti-clotting drugs
Reuters
Fri, 03/17/17 - 09:25 am
stroke
atrial fibrillation
Pradaxa
Xarelto
Eliquis
bloodthinners
As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters
Fierce Pharma
Sat, 03/11/17 - 11:55 am
Bayer
intellectual property
India
exporting
Xarelto
Nexavar
The Lawsuits Keep Coming for Johnson & Johnson
Bloomberg
Fri, 03/10/17 - 09:56 am
JNJ
Xarelto
consumer health
hip implants
pelvic mesh
Bayer touts Xarelto strength on heels of COMPASS data
BioPharma Dive
Thu, 02/23/17 - 09:37 pm
Bayer
Xarelto
bloodthinners
Bayer's blood thinner also effective for artery disease
Yahoo/Reuters
Wed, 02/8/17 - 09:34 pm
Bayer
bloodthinners
Xarelto
peripheral artery disease
coronary artery disease
U.S. FDA clears Xarelto blood thinner despite faulty trial device
Yahoo/Reuters
Tue, 10/11/16 - 09:38 pm
FDA
Xarelto
blood thinners
JNJ
Bayer raises sales targets for top-selling drugs after Monsanto deal
Yahoo/Reuters
Tue, 09/20/16 - 09:53 am
Bayer
Monsanto
M&A
Xarelto
Eylea
Bayer hikes guidance as its pharma darlings Xarelto, Eylea power better-than-expected sales growth
Fierce Pharma
Wed, 07/27/16 - 03:06 pm
Bayer
earnings
Eylea
Xarelto
Bayer's Xarelto projected to become top-selling drug in Europe by 2022
BioPharma Dive
Thu, 05/5/16 - 09:34 am
Bayer
Xarelto
bloodthinners
Europe
Court document accuses J&J, Bayer of keeping mum about Xarelto lab data
Fierce Pharma
Thu, 03/3/16 - 03:09 pm
JNJ
Bayer
Xarelto
clinical trial data
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »